Article
Establish a novel tumor budding-related signature to predict prognosis and guide clinical therapy in colorectal cancer
25 Jan 2024
Abstract excerpt
Tumor budding is a long-established independent adverse prognostic marker for colorectal cancer (CRC), yet assessment of tumor budding was not reproducible. Therefore, development of precise diagnostic approaches to tumor budding is in demand. In this study, we first performed bioinformatic analysis in our single-center CRC patients' cohort (n = 84) and identified tumor budding-associated hub genes using the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
